华纳药厂(688799.SH)获得重酒石酸去甲肾上腺素注射液药品注册证书

Core Viewpoint - Warner Pharmaceuticals (688799.SH) has received approval from the National Medical Products Administration for the registration certificate of its drug, Dexmedetomidine Injection, which is used for treating acute hypotension and as an auxiliary treatment for cardiac arrest [1] Group 1 - The drug is indicated for restoring blood pressure in acute hypotensive states and can assist in the treatment of cardiac arrest and maintaining blood pressure post-resuscitation [1] - It is also used as an auxiliary treatment for shock caused by insufficient blood volume, helping to temporarily maintain cerebral and coronary perfusion until volume resuscitation takes effect [1] - The Dexmedetomidine Injection has been classified as a Category 3 chemical drug and is considered to have passed the consistency evaluation [1]